Sionna Therapeutics, Inc. SION
5.23
0.00
0.00%
as of 25 Sep
- Market cap
- $241.9M
- P/E
- 0.0×
Follow SION
| Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|
Current Ratio |
4.88 | 14.49 | 20.61 |
Net Debt/EBITDA |
0.76 | 2.02 | 2.58 |
Debt/Assets |
0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 |
Asset Turnover |
— | 0.00 | 0.00 |
Operating CF/Net income |
0.92 | 0.86 | 0.88 |
Capex/Depreciation |
11.63 | 0.01 | 0.16 |
Interest Coverage |
0.00 | 0.00 | 0.00 |
| 0.00% | 44.29% | (105.18%) | |
| 0.00% | (51.90%) | (29.42%) | |
ROIC |
0.00% | 0.00% | (78.38%) |
Return on Tangible Assets |
(137.89%) | (43.13%) | (32.45%) |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(15.28) | (13.69) | (1.67) |
Cash per Share |
13.13 | 38.23 | 5.90 |
Shareholders Equity per Share |
(39.17) | (42.42) | 7.68 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 |
Book value per Share |
(39.17) | (42.42) | 7.68 |
Free Cash Flow |
(44.81) | (52.81) | (66.67) |
Working Capital |
31.17 | 140.57 | 229.71 |
Capital Expenditures |
(1.12) | (0.03) | (0.38) |
Net Current Asset Value |
(127.62) | (198.47) | 222.30 |
| Other line items | |||
Quick Ratio |
4.79 | 14.16 | 20.14 |
Depreciation/Fixed assets |
(0.03) | (0.95) | (1.08) |
Cash ROIC |
61.30% | 341.60% | (12.63%) |
Accounts Payable Turnover |
— | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 0.00 |
Revenue per Share |
0.00 | 0.00 | 0.00 |
Operating CF per Share |
(14.90) | (13.68) | (1.66) |
Capex per Share |
(0.38) | (0.01) | (0.01) |
Average Payables |
— | 0.95 | 0.98 |
Average Assets |
— | 118.85 | 255.85 |
Average Common Equity |
— | (139.30) | 71.56 |
Capex to Sales |
0.00 | 0.00 | 0.00 |
Net Profit Margin |
0.00% | 0.00% | 0.00% |
Columns are period end dates